SA517381232B1 - تركيبات وأطقم للإنضار الإنزيمي وطرق لاستخدامها - Google Patents
تركيبات وأطقم للإنضار الإنزيمي وطرق لاستخدامهاInfo
- Publication number
- SA517381232B1 SA517381232B1 SA517381232A SA517381232A SA517381232B1 SA 517381232 B1 SA517381232 B1 SA 517381232B1 SA 517381232 A SA517381232 A SA 517381232A SA 517381232 A SA517381232 A SA 517381232A SA 517381232 B1 SA517381232 B1 SA 517381232B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- amylase
- kits
- compositions
- methods
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01002—Beta-amylase (3.2.1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01003—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22032—Stem bromelain (3.4.22.32)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24007—Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L2300/206—Biguanides, e.g. chlorohexidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Materials Engineering (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
يتعلق الاختراع الحالي بإنزيم إنضار لنسيج نخري debridement enzyme for necrotic tissue غير معتمد على النشاط الإنزيمي المُفكك للبروتين proteolytic enzymatic activity ولكنه يستخدم بدلًا من ذلك فصيلة الأميلاز amylase من الإنزيمات. الأميلازات amylases (ألفا، بيتا، جاما-أميلاز) (α-, ß-, γ-amylase) معروفة بانشطار روابط α-الجليكوسيدية α-glycosidic bonds لمتعددات السكاريد polysaccharides ، منتجة شظايا كربوهيدرات/سكر carbohydrate/sugar fragments منخفضة الوزن الجزيئي. وجد الآن أن ألفا- أميلاز α-amylase فعال في إنضار النسيج الذي يفتقر إلى الحيوية debridement of devitalized tissue. شكل 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/511,912 US9592280B2 (en) | 2014-10-10 | 2014-10-10 | Compositions and kits for enzymatic debridement and methods of using the same |
PCT/US2015/054682 WO2016057788A1 (en) | 2014-10-10 | 2015-10-08 | Compositions and kits for enzymatic debridement and methods of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
SA517381232B1 true SA517381232B1 (ar) | 2022-08-29 |
Family
ID=55653768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SA517381232A SA517381232B1 (ar) | 2014-10-10 | 2017-04-03 | تركيبات وأطقم للإنضار الإنزيمي وطرق لاستخدامها |
Country Status (20)
Country | Link |
---|---|
US (1) | US9592280B2 (ar) |
EP (1) | EP3204037B1 (ar) |
JP (1) | JP6710862B2 (ar) |
KR (2) | KR20170065551A (ar) |
CN (1) | CN107106663B (ar) |
AU (1) | AU2015330888B2 (ar) |
BR (1) | BR112017006939B1 (ar) |
CA (1) | CA2963811A1 (ar) |
CO (1) | CO2017003290A2 (ar) |
DK (1) | DK3204037T3 (ar) |
ES (1) | ES2938202T3 (ar) |
FI (1) | FI3204037T3 (ar) |
IL (1) | IL251546A (ar) |
MX (1) | MX2017004199A (ar) |
PH (1) | PH12017500663A1 (ar) |
PT (1) | PT3204037T (ar) |
SA (1) | SA517381232B1 (ar) |
SG (1) | SG11201702871WA (ar) |
UA (1) | UA126367C2 (ar) |
WO (1) | WO2016057788A1 (ar) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017130204A1 (en) | 2016-01-31 | 2017-08-03 | Mediwound Ltd. | Debriding composition for treating wounds |
AU2018375567A1 (en) * | 2017-11-30 | 2020-05-28 | Hollister Incorporated | Wound debridement composition and method for treating wounds |
FI3533458T3 (fi) | 2018-03-02 | 2023-07-20 | Upm Kymmene Corp | Lääketieteellinen tuote, joka käsittää bioaktiivisen molekyylin, joka on kiinnitetty paikoilleen nanofibrilliselluloosaan, sekä menetelmä sen valmistamiseksi |
EP4295869A3 (en) * | 2019-06-03 | 2024-03-20 | Convatec Limited | Methods and devices to disrupt and contain pathogens |
KR20240028210A (ko) * | 2022-08-24 | 2024-03-05 | 주식회사 티앤알바이오팹 | 단백질 추출물을 포함하는 하이드로겔 기반의 국소 창상 피복재 |
CN115671369B (zh) * | 2022-11-09 | 2023-10-27 | 华东理工大学 | 一种按需可拆的水凝胶组织粘合剂及其制备方法 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA733072A (en) * | 1966-04-26 | J. Beckhorn Edward | Debridement agent | |
US2120667A (en) | 1937-12-01 | 1938-06-14 | Lakeland Foundation | Therapeutic agent for use in the treatment of infection |
US2917433A (en) | 1956-04-02 | 1959-12-15 | Rystan Company | Stable aqueous papain topical compositions |
US3003917A (en) * | 1959-01-14 | 1961-10-10 | Nat Drug Co | Wound healing composition |
US3409719A (en) | 1967-05-23 | 1968-11-05 | Baxter Laboratories Inc | Debridement agent |
US3681197A (en) * | 1969-01-02 | 1972-08-01 | Clarence T Smith | Method and solution for maintaining biological activity in enzymes |
US4652524A (en) | 1980-10-02 | 1987-03-24 | Ivan E. Modrovich | Soluble stabilized enzymes |
EP0133438A1 (en) | 1983-01-21 | 1985-02-27 | Advanced Drug Technology Corporation | Enzyme ointment |
US4719235A (en) | 1984-10-16 | 1988-01-12 | Gerald N. Kern | Methods and compositions for treating viral infection |
US4668228A (en) | 1985-03-12 | 1987-05-26 | Johnson & Johnson Products, Inc. | Debriding tape |
US4885310A (en) | 1985-05-09 | 1989-12-05 | Gerald N. Kern | Anti-fungal methods and agent |
US4717737A (en) | 1985-06-05 | 1988-01-05 | Gerald N. Kern | Anti-bacterial methods and agent |
US4772465A (en) | 1986-10-27 | 1988-09-20 | Miles Laboratories, Inc. | Method of treating polymicrobial burn wound sepsis with a combination therapy of ciprofloxacin and pseudomonas immune globulin |
US5206026A (en) | 1988-05-24 | 1993-04-27 | Sharik Clyde L | Instantaneous delivery film |
US5120656A (en) | 1989-08-18 | 1992-06-09 | Osteotech, Inc. | Process for debriding bone |
DE4140473C2 (de) | 1991-12-09 | 1995-12-21 | Schuelke & Mayr Gmbh | Hautantiseptikum und Händedesinfektionsmittel |
US5543149A (en) | 1995-03-01 | 1996-08-06 | Rubin; Stan M. | Treatment for insect bites |
US5670142A (en) | 1996-07-08 | 1997-09-23 | Donald Neudecker | Treatment for itch of chicken pox |
WO1999046368A2 (en) | 1998-03-13 | 1999-09-16 | Biomarin Pharmaceuticals | Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment |
AU2001268953A1 (en) | 2000-07-21 | 2002-02-05 | Novozymes A/S | Antimicrobial compositions |
US6548556B2 (en) | 2000-12-27 | 2003-04-15 | Healthpoint, Ltd. | Stable enzymatic wound debrider |
US7223386B2 (en) * | 2002-03-11 | 2007-05-29 | Dow Corning Corporation | Preparations for topical skin use and treatment |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
US20070237812A1 (en) * | 2006-04-11 | 2007-10-11 | Tyco Healthcare Group | Multi-layer wound dressings |
AU2003213273A1 (en) * | 2003-02-26 | 2004-09-28 | Genencor International, Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
WO2005035010A1 (en) | 2003-10-10 | 2005-04-21 | Coloplast A/S | Wound dressing containing proteolytic enzymes |
IL165334A0 (en) | 2004-11-22 | 2006-01-15 | Mediwound Ltd | Debriding composition from bromelain and methods of producing same |
WO2008063229A2 (en) | 2006-05-12 | 2008-05-29 | Livingston James A | Enzymatic debridement therapy for abnormal cell proliferation |
US7629158B2 (en) | 2006-06-16 | 2009-12-08 | The Procter & Gamble Company | Cleaning and/or treatment compositions |
JP2007262099A (ja) * | 2007-07-19 | 2007-10-11 | Yamachu:Kk | 紫外線対抗化粧用組成物 |
WO2010004367A1 (en) | 2008-07-10 | 2010-01-14 | Life Science Investments Ltd | Use of a mixture of superoxide dismutase and catalase for treating pruritus and alleviating its symptoms |
JP5684725B2 (ja) * | 2009-01-06 | 2015-03-18 | キュレロン リミテッド ライアビリティ カンパニー | 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法 |
US8486664B2 (en) | 2010-07-29 | 2013-07-16 | Basf Se | Enzymatic production of an ethylenically unsaturated glycoside using polysaccharides |
ES2482610T3 (es) | 2010-07-29 | 2014-08-04 | Basf Se | Procedimiento de producción de glucósidos de derivados de acrilato que emplean polisacáridos y glicosidasas o glicosiltransferasas |
CN103687610A (zh) | 2011-05-12 | 2014-03-26 | 史密夫和内修整形外科股份公司 | 含有蜂蜜曲霉蛋白酶的伤口清创组合物和使用其治疗伤口的方法 |
US20140194803A1 (en) * | 2011-07-28 | 2014-07-10 | Regents Of The University Of Minnestoa | Wound-healing compositions and method of use |
EP2809341B1 (en) * | 2012-02-02 | 2020-12-30 | Galenagen, LLC | Enzyme compositions and use thereof for wound healing |
WO2013155476A1 (en) | 2012-04-12 | 2013-10-17 | Integrative Enzymatics, Inc. | Composition and method for modulating inflammatory molecules with amylase |
US20150086529A1 (en) | 2013-09-26 | 2015-03-26 | Barbara Ann Hillenbrand | Therapeutic Burn Gel |
US20160101166A1 (en) * | 2014-10-10 | 2016-04-14 | Rochal Industries, Llp | Compositions and kits for treating pruritus and methods of using the same |
-
2014
- 2014-10-10 US US14/511,912 patent/US9592280B2/en active Active
-
2015
- 2015-10-08 JP JP2017518221A patent/JP6710862B2/ja active Active
- 2015-10-08 PT PT158495580T patent/PT3204037T/pt unknown
- 2015-10-08 WO PCT/US2015/054682 patent/WO2016057788A1/en active Application Filing
- 2015-10-08 KR KR1020177010545A patent/KR20170065551A/ko active Application Filing
- 2015-10-08 ES ES15849558T patent/ES2938202T3/es active Active
- 2015-10-08 SG SG11201702871WA patent/SG11201702871WA/en unknown
- 2015-10-08 KR KR1020237017329A patent/KR20230075529A/ko not_active Application Discontinuation
- 2015-10-08 CN CN201580053958.XA patent/CN107106663B/zh active Active
- 2015-10-08 EP EP15849558.0A patent/EP3204037B1/en active Active
- 2015-10-08 MX MX2017004199A patent/MX2017004199A/es unknown
- 2015-10-08 UA UAA201703089A patent/UA126367C2/uk unknown
- 2015-10-08 FI FIEP15849558.0T patent/FI3204037T3/fi active
- 2015-10-08 BR BR112017006939-3A patent/BR112017006939B1/pt active IP Right Grant
- 2015-10-08 DK DK15849558.0T patent/DK3204037T3/da active
- 2015-10-08 CA CA2963811A patent/CA2963811A1/en active Pending
- 2015-10-08 AU AU2015330888A patent/AU2015330888B2/en active Active
-
2017
- 2017-04-03 SA SA517381232A patent/SA517381232B1/ar unknown
- 2017-04-04 IL IL251546A patent/IL251546A/en active IP Right Grant
- 2017-04-04 CO CONC2017/0003290A patent/CO2017003290A2/es unknown
- 2017-04-07 PH PH12017500663A patent/PH12017500663A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT3204037T (pt) | 2023-01-31 |
WO2016057788A1 (en) | 2016-04-14 |
EP3204037A1 (en) | 2017-08-16 |
DK3204037T3 (da) | 2023-01-23 |
IL251546A (en) | 2017-11-30 |
IL251546A0 (en) | 2017-05-29 |
MX2017004199A (es) | 2017-07-19 |
US20160101165A1 (en) | 2016-04-14 |
ES2938202T3 (es) | 2023-04-05 |
BR112017006939B1 (pt) | 2023-11-28 |
CN107106663B (zh) | 2022-12-06 |
AU2015330888A1 (en) | 2017-04-27 |
UA126367C2 (uk) | 2022-09-28 |
AU2015330888B2 (en) | 2021-04-01 |
BR112017006939A2 (pt) | 2018-01-09 |
CO2017003290A2 (es) | 2017-06-30 |
JP6710862B2 (ja) | 2020-06-17 |
SG11201702871WA (en) | 2017-05-30 |
US9592280B2 (en) | 2017-03-14 |
JP2017530165A (ja) | 2017-10-12 |
EP3204037A4 (en) | 2018-05-30 |
KR20170065551A (ko) | 2017-06-13 |
FI3204037T3 (fi) | 2023-03-01 |
CN107106663A (zh) | 2017-08-29 |
KR20230075529A (ko) | 2023-05-31 |
CA2963811A1 (en) | 2016-04-14 |
EP3204037B1 (en) | 2022-12-07 |
PH12017500663A1 (en) | 2017-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SA517381232B1 (ar) | تركيبات وأطقم للإنضار الإنزيمي وطرق لاستخدامها | |
MX2018014890A (es) | Composiciones de limpieza que comprenden enzimas. | |
NZ730769A (en) | Compositions and kits for treating pruritus and methods of using the same | |
CO2019014682A2 (es) | Composiciones y métodos para enzimas de internalización | |
EP3957711A3 (en) | Detergent composition comprising amylase and protease variants | |
PH12019502279A1 (en) | Cleaning compositions and uses thereof | |
MX2023002841A (es) | Composiciones detergentes y sus usos. | |
WO2020070063A3 (en) | Detergent compositions and uses thereof | |
MY202018A (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies | |
WO2018229236A3 (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
EP4234693A3 (en) | Bacillus gibsonii-clade serine proteases | |
MX2019006421A (es) | Composiciones de limpieza que incluyen enzimas. | |
MX2016006489A (es) | Alfa-amilasas variantes que tienen susceptibilidad reducida a la escision por proteasas y metodos de uso. | |
MX2016001315A (es) | Variantes de enzimas. | |
MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
MX2019009229A (es) | Novedosas variantes enzimaticas que degradan la nicotina. | |
MY189867A (en) | Solubilization of msw with blend enzymes | |
EP4242294A3 (en) | B. amyloliquefaciens strain and therapeutic use | |
MX2019006422A (es) | Composiciones de limpieza que incluyen enzimas. | |
MY202423A (en) | Biosynthetic production of steviol glycoside rebaudioside d4 from rebaudioside e | |
NZ767856A (en) | Solid enzymatic detergent compositions and methods of use and manufacture | |
MX2021005157A (es) | Composiciones, metodos para hacer y utilizar extracto de salvado de arroz. | |
WO2017058003A3 (en) | Method of isolating mesenchymal stromal cells and applications for tissue engineering | |
WO2020109233A3 (en) | Trmt2a inhibitors for use in the treatment of polyglutamine diseases | |
UY38035A (es) | Cebada con actividad enzimática hidrolitica incrementada |